Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the ...

Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, ...

The VARIPULSE™ Platform is the first Pulsed Field Ablation (PFA) system fully integrated with the CARTO™ 3 electroanatomical mapping system, designed to drive efficiency, reproducibility, and ...

Boston Scientific has claimed a new approval from the FDA for its Farapulse pulsed field ablation system, expanding its use ...

The pulsed field ablation developer Kardium has collected $250 million in funding to gear up for the commercial expansion of ...

Kardium announced today that it raised $250 million in a new financing round to support the launch of its pulsed field ...

Marlou Janssen, Board Member at Field Medical, Sonion, Acarix, EBAMed, and Inspiration Healthcare - Experienced executive and ...

Boston Scientific receives US FDA approval for expanded labelling of Farapulse PFA System: Marlborough, Massachusetts Tuesday, July 8, 2025, 11:00 Hrs [IST] Boston Scientific Corp ...

Field Medical announced today that it has closed a Series B funding round worth proceeds totaling $35 million.

The funding will support the launch of the VERITAS trial while strengthening the company's clinical and regulatory ...